HIV治愈的阻断与锁定策略:从didehydro-cortistatin A中获得的经验
抗逆转录病毒治疗可有效控制HIV感染,但潜伏感染细胞库持续存在,是HIV治愈的主要障碍。阻断与锁定策略旨在通过转录和表观遗传沉默前病毒,在无治疗时阻断病毒再激活。本文综述didehydro-cortistatin A抑制Tat转录反馈环路放大导致HIV启动子表观遗传沉默的机制,并讨论该策略的益处与局限。
要点
- 阻断与锁定策略通过表观遗传沉默前病毒实现功能性治愈。
- didehydro-cortistatin A抑制Tat转录反馈环路放大。
- 该策略可在无治疗时阻断病毒再激活,但存在益处与局限。
核心结论
- 阻断与锁定策略旨在转录和表观遗传沉默前病毒,在无治疗时阻断病毒再激活,预防疾病进展和传播。
研究设计与样本
- 本文为综述,基于didehydro-cortistatin A(HIV转录激活因子Tat的抑制剂)的活性,回顾其抑制Tat反馈环路转录放大导致HIV启动子表观遗传沉默的机制。
主要发现
- didehydro-cortistatin A抑制Tat的反馈环路转录放大,导致HIV启动子表观遗传沉默。
临床怎么用
- 阻断与锁定策略作为HIV功能性治愈的探索方向,需权衡其益处与局限性。
局限性
- 本文讨论了阻断与锁定策略用于HIV治愈的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antiretroviral therapy effectively controls human immunodeficiency virus (HIV) infection. However, a reservoir of latently infected cells persists under suppressive therapy, constituting a major barrier to an HIV cure. The block-and-lock approach to a functional cure aims at the transcriptional and epigenetic silencing of proviruses, blocking viral reactivation in the absence of therapy, preventing disease progression and transmission, despite the presence of detectable integrated proviruses. This approach has been put forward for exploration based on the activity of didehydro-cortistatin A, an inhibitor of the HIV transcriptional activator Tat. Here we review the mechanisms by which didehydro-cortistatin A inhibition of Tat's feedback loop transcriptional amplification results in epigenetic silencing of the HIV promoter, and we discuss the benefits and limitations of the block-and-lock approach for an HIV cure.
引用
- Li C, Mori L, Valente ST, et al. The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A. J Infect Dis. 2021. PMID: 33586776. doi:10.1093/infdis/jiaa681
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。